23 -1 (75) 2025 - Pulatova P.Kh. - THE CURRENT DIAGNOSIS OF KIDNEY DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE

THE CURRENT DIAGNOSIS OF KIDNEY DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE

Pulatova P.Kh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The problem of kidney dysfunction and its impact on outcomes in different groups of cardiac patients continue to being widely used. Kidney dysfunction is associated with a number of traditional cardiovascular risk factors. The use of new biomarkers, cystatin C in particular, to identify kidney injury can contribute to the improvement of early prediction of a risk for renal failure (RF). Cystatin C satisfies many characteristics as an ideal biomarker that can assist in not only detecting the early forms of kidney injury, but also in assessing the risk of RF, the needs for renal replacement therapy, and the risk of death in intensive care unit patients in cardiac clinics. Kidney involvement in many diseases, including those that are not initially regarded as renal, necessitates the elaboration of uniform approaches to managing patients with identified chronic RF, especially to the early prevention and treatment of its complications, such as anemia, phosphorus-calcium metabolic disorders, which substantially worsen the prognosis of other diseases.

Key words: renal dysfunction, coronary heart disease, cystatin C.

First page

116

Last page

121

For citation:Pulatova P.Kh. - THE CURRENT DIAGNOSIS OF KIDNEY DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE//New Day in Medicine 1(75)2025 116-121 https://https://newdayworldmedicine.com/en/new_day_medicine/1-75-2025

List of References

  1. Кардиоваскулярная профилактика. Национальные рекомендации. //Кардиоваск тер и проф 2011;6(2):1-64.
  2. Cardiovascular diseases. Fact sheet № 317. WHO. September 2011. http://www.who.int/mediacentre/factsheets/fs317/en
  3. Томилина Н.А. Проблема сердечно-сосудистых заболеваний при хронической почечной недостаточности. //Нефрол диал 2003;1:15-24.
  4. Макарычева О.В., Хмара Т.Н., Якушева Н.В. и др. Дисфункция почек при поступлении в блок кардиореанимации — фактор риска госпитальной летальности у больных с острым инфарктом миокарда с подъемом сегмента ST.// Креатив кардиол 2010;2:35-40.
  5. Santopinto J.J., Fox K., Goldberg R.J. et al. on behalf of the GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). //Heart 2003;89:1003-1008.
  6. Marenzi G., Assanelli E., Campodonico J. et al. Acute kidney injury in ST-segmrnt elevation acute myocardial infarction complicated by cardiogenic shock at admission. //Crit Care Med 2010;38:438-444.
  7. Masoudi F.A., Plomondon M.E., Magid D.J. et al. Renal insufficiency and mortality from acute coronary syndromes. //Am Heart J 2004;147(4):623-629.
  8. Mueller C., Neumann F.-J., Perruchoud A.P., Buettner H.J. Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention. //Heart 2004;90(8):902-907.
  9. Каретникова В.Н., Зыков М.В., Кашталап В.В. и др. Значение почечной дисфункции для госпитального прогноза больных инфарктом миокарда с подъемом сегмента ST. //Сердце 2013;5:284-289.
  10. Ефремова Е.В., Шутов А.М., Сабитов И.А. Коморбидность и приверженность к лечению при хронической сердечной недостаточности. //Сердеч недостат 2013;1:40-46.
  11. Gleeson T.G., Bulugahapitiya S. Contrast-induced nephropathy. //AJR Am J Roentgenol 2004;183:1673-1689.
  12. Han Y., Zhu G., Han L. et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. //J Am Coll Cardiol 2013. http://dx.doi.org/10.1016/j.jacc.2013.09.017.
  13. Nauck M.A., Barnett A.H., Filetti S., Tambascia M.A. The diabetes patient with renal impairment: hyperglycemia management across the spectrum of CKD. //Medscape Education Diabetes Endocrinology 2012. http://www.medscape.org/viewarticle/772418_transcript
  14. Scheen A.J. Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease. //Expert Opin Drug Metab Toxicol 2013;9(5):529-550.
  15. Scheen A.J. How I treat ... with metformin a diabetic patient with moderate renal insufficiency. //Rev Med Liege 2013;68(4):190-195.

    file

    download